Skip to main content

Breast Cancer Research and Treatment

Ausgabe 2/2024

Inhalt (20 Artikel)

Review

Breast lymphedema following breast-conserving treatment for breast cancer: current status and future directions

Cheryl L. Brunelle, John Boyages, Amanda W. Jung, Hiroo Suami, Brooke C. Juhel, Asha Heydon-White, Helen Mackie, Shinn-Huey Shirley Chou, Vincent S. Paramanandam, Louise Koelmeyer, Alphonse G. Taghian

Open Access Clinical trial

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY

Judith Balmaña, Peter A. Fasching, Fergus J. Couch, Suzette Delaloge, Intidhar Labidi-Galy, Joyce O’Shaughnessy, Yeon Hee Park, Andrea F. Eisen, Benoit You, Hughes Bourgeois, Anthony Gonçalves, Zoe Kemp, Angela Swampillai, Tomasz Jankowski, Joo Hyuk Sohn, Elena Poddubskaya, Guzel Mukhametshina, Sercan Aksoy, Constanta V. Timcheva, Tjoung-Won Park-Simon, Antonio Antón-Torres, Ellie John, Katherine Baria, Isabel Gibson, Karen A. Gelmon, Tatyana Koynova, Vasil Popov, Constanta Timcheva, Antoaneta Tomova, Andrea Eisen, Karen Gelmon, Julie Lemieux, Paule Augereau, Fernando Bazan, Célia Becuwe, Hugues Bourgeois, Camille Chakiba, Mohamad Chehimi, Caroline Cheneau, Florence Dalenc, Eléonore de Guillebon, Thibault de La Motte Rouge, Jean-Sébastien Frenel, Anthony Gonçalves, Julien Grenier, Anne Claire Hardy-Bessard, Regine Lamy, Christelle Levy, Alain Lortholary, Audrey Mailliez, Jacques Medioni, Anne Patsouris, Dominique Spaeth, Luis Teixeira, Isabelle Tennevet, Laurence Venat-Bouvet, Cristian Villanueva, Benoit You, Johannes Ettl, Peter Fasching, Bernd Gerber, Claus Alexander Hanusch, Oliver Hoffmann, Tjoung-Won Park-Simon, Wolfram Malter, Mattea Reinisch, Joke Tio, Pauline Wimberger, Katalin Boer, Magdolna Dank, Alberto Ballestrero, Giampaolo Bianchini, Laura Biganzoli, Roberto Bordonaro, Francesco Cognetti, Enrico Cortesi, Michelino De Laurentiis, Sabino De Placido, Luca Gianni, Valentina Guarneri, Paulo Marchetti, Filippo Montemurro, Anna Maria Mosconi, Giuseppe Naso, Fabio Puglisi, Armando Santoro, Claudio Zamagni, Hiroji Iwata, Seung-Jin Kim, Seigo Nakamura , Yee Soo Chae, Eun Kyung Cho, Jee Hyun Kim, Seock-Ah Im, Keun Seok Lee , Yeon Hee Park, Joo Hyuk Sohn, Tomasz Byrski, Tomasz Huzarski, Tomasz Jankowski, Bozena Kukielka-Budny, Aleksandra Lacko, Zbigniew Nowecki, Elzbieta Senkus-Konefka, Renata Szoszkiewicz, Rafal Tarnawski, Timur Andabekov, Mikhail Dvorkin, Viktoria Dvornichenko, Fedor Moiseenko, Guzel Mukhametshina, Elena Poddubskaya, Ekaterina Popova, Anna Tarasova, Dina Sakaeva, Marina Shomova, Anna Vats, Bárbara Adamo, Raquel Andrés Conejero, Antonio Antón Torres, Judith Balmaña Gelpi, Blanca Cantos Sánchez de Ibarguen, Josefina Cruz Jurado, Nieves Díaz Fernández, Alejandro Falcón González, Juan Garcia, Santiago González Santiago, Fernando Henao Carrasco, Isabel Lorenzo Lorenzo, Fernando Moreno Antón, Beatriz Rojas García, Salomón Menjón Beltrán, Marta Santisteban, Agostina Stradella, Ming-Feng Hou, Chiun-Sheng Huang, Yung-Chang Lin, Ling-Ming Tseng, Hwei-Chung Wang, Sercan Aksoy, Cagatay Arslan, Mehmet Artac, Adnan Aydiner, Umut Disel, Metin Ozkan, Ozgur Ozyilkan, Emel Yaman Sezer, Tarkan Yetisyigit, Anne Armstrong, Sophie Barrett, Annabel Borley, Zoe Kemp, Caroline Michie, Mukesh Mukesh, Timothy Perren, Angela Swampillai, Madhu Chaudhry, Tammy Young

Open Access Clinical trial

Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials

Hope S. Rugo, Catherine H. Van Poznak, Patrick Neven, Iwona Danielewicz, Soo Chin Lee, Mario Campone, Jeannie Y. K. Chik, Estela Vega Alonso, Bjørn Naume, Etienne Brain, Jonathan M. Siegel, Rui Li, Deise Uema, Volker J. Wagner, Robert E. Coleman

Open Access Clinical trial

Comparison of cisplatin-based versus standard preoperative chemotherapy in patients with operable triple-negative breast cancer: propensity score matching and inverse probability of treatment weighting analysis

Ayane Yamaguchi, Kosuke Kawaguchi, Kana Kawanishi, Yurina Maeshima, Akiyoshi Nakakura, Tatsuki R. Kataoka, Sachiko Takahara, Shunsaku Nakagawa, Atsushi Yonezawa, Masahiro Takada, Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Takeshi Kotake, Eiji Suzuki, Hanako Shimizu, Masae Torii, Satoshi Morita, Hiroshi Ishiguro, Masakazu Toi

Clinical trial

Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study

Sabine R. de Wild, Linetta B. Koppert, Linda de Munck, Marie-Jeanne T. F. D. Vrancken Peeters, Sabine Siesling, Marjolein L. Smidt, Janine M. Simons

Clinical trial

Clinical outcomes after 1 versus 2-3 lines of neoadjuvant therapy in stage III inflammatory breast cancer

Faina Nakhlis, Samuel M. Niman, Naoto T. Ueno, Elizabeth Troll, Sean Ryan, Eren Yeh, Laura Warren, Jennifer Bellon, Beth Harrison, Toshiaki Iwase, H. T. Carisa Le-Petross, Sadia Saleem, Mediget Teshome, Gary J. Whitman, Wendy A. Woodward, Beth Overmoyer, Sara M. Tolaney, Meredith Regan, Filipa Lynce, Rachel M. Layman

Open Access Clinical trial

The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial

Yajing Zhu, Ioannis Zerdes, Alexios Matikas, Ivette Raices Cruz, Mattias Bergqvist, Ellinor Elinder, Ana Bosch, Henrik Lindman, Zakaria Einbeigi, Anne Andersson, Lena Carlsson, Ann Charlotte Dreifaldt, Erika Isaksson-Friman, Mats Hellstrom, Hemming Johansson, Kang Wang, Jonas C. S. Bergh, Thomas Hatschek, Theodoros Foukakis

Epidemiology

Reproductive risk factors for breast cancer and association with novel breast density measurements among Hispanic, Black, and White women

Mollie E. Barnard, Natalie C. DuPré, John J. Heine, Erin E. Fowler, Divya J. Murthy, Rebecca L. Nelleke, Ariane Chan, Erica T. Warner, Rulla M. Tamimi

Epidemiology

Psychosocial stressors and breast cancer gene expression in the Black Women’s Health Study

Mollie E. Barnard, Xutao Wang, Jessica L. Petrick, Gary R. Zirpoli, Dennis Jones, W. Evan Johnson, Julie R. Palmer

Epidemiology

Survival, treatment patterns, and costs of HER2+ metastatic breast cancer patients in Ontario between 2005 to 2020

S. J. Seung, H. Saherawala, D. Moldaver, S. Shokar, C. Ammendolea, C. Brezden-Masley

Open Access Epidemiology

Is there an association between endometriosis and subsequent breast cancer? A retrospective cohort study from Germany

Niklas Gremke, Sebastian Griewing, Jacob Göhring, Anna Isselhard, Uwe Wagner, Karel Kostev, Matthias Kalder

Epidemiology

Second primary cancers among females with a first primary breast cancer: a population-based study in Northern Portugal

Elisabete Gonçalves, Filipa Fontes, Jéssica Rocha Rodrigues, Rita Calisto, Maria José Bento, Nuno Lunet, Samantha Morais

Open Access Epidemiology

Social inequalities in the use of physiotherapy in women diagnosed with breast cancer in Barcelona: DAMA cohort

Rocio Cogollos-de-la-Peña, Anaís Álvarez-Vargas, Fernando Domínguez-Navarro, Albert Espelt, Laura Fuentes-Aparicio, Rosa Puigpinós‑Riera

Epidemiology

Targeted axillary dissection: worldwide variations in clinical practice

Michalis Kontos, Prodromos Kanavidis, Thorsten Kühn, Yazan Masannat, Bahadir Gulluoglu, Eduardo Gonzalez, Melanie Walker, A. J. Collins, M. T. Nano, Kim Heron, Beth Penington, Mike He, Norman Janu, Katrina Read, Jose Cid Fernandez, Belinda Brown, Aashit Shah, Kylie Snook, Sarah Forsyth, Janne Bingham, Jocelyn Lippey, Joel Symonds, Alec Winder, Nita Bartlett, Petar Vujovic, Jenny Gough, Sarah Birks, Farid Meybodi, Saud Hamza, Elisabeth Elder, Heidi Stranzl, Tahmina Kosayeva, Glenn Vergauwen, Jaime Letzkus, Gilberto Benitez, Eduardo Cabrera, Evros Kitiris, Michalis Kailides, Patricio Corral, Khaled Mohamed Abdelwahab Ali, Laura Niinikoski, Kerstin Weinand, Stephan Hasmüller, Conny Kurz, Hans-Christian Kolberg, Ingo Thalmann, Maggie Banys-Paluchowski, Aikaterini Manika, Vasileios Venizelos, Georgios Metaxas, Lazaros Papadopoulos, Ioannis Natsiopoulos, Eleftheria Ignatiadou, Rodoniki Iosifidou, Ioannis Askoksilakis, Nikolaos Michalopoulos, Grigorios Xepapadakis, Serena Yu Yan Wong, Karishma Kirti, Roghieh Nooripour, Alessandra Invento, Lea Regolo, Corrado Chiappa, Maria-Grazia Lazzaretti, Andrea Sibilio, Viviana-Enrica Galimberti, Denise Mattar, Silvia Michieletto, Rosa Di Micco, Teresa Di Palma, Oreste D. Gentilini, Nicola Rocco, Mauro Porpiglia, Mervat Alsaleh, Ibtisam Albader, Sergio Aguilar-Villanueva, Emiel Rutges, Eva Juhasz, Nicola Davis, Stan Govender, Khaled Sharaf, Lia Pamela Rebaza Vasquez, Aldine Basa, Dawid Murawa, David Pinto, Bonci Eduard-Alexandru, Florin Bobirca, Elena Adelina Toma, Bogdan Diaconescu, Radu Mihail Mirica, Adrian Udrea, Silvia Brotea-Mosoiu, Gabriel Dimofte, Lunca Sorinel, Octav Ginghina, Gata Vlad Alexandru, Mihai-Stefan Muresan, Ana-Maria Musina, Lolwah Alriyees, Chi Wei Mok, Andraz Perhavec, Laura Comin, José Ignacio Sánchez-Méndez, Gloria Ortega-Perez, Jana De Boniface, Ira Oikonomou, Andreas Karakatsanis, Christoph Tausch, Walter Weber, Maria-Luisa Gasparri, Ahmet Necati Sanli, Seymur Abdullayev, Melek Gokova, Abut Kebudi, Gultekin Ozan Kucuk, Baha Zengel, Tolga Kalayci, Lutfi Dogan, Betul Bozkurt, Semra Gunay, Elina Shaari, Ashutosh Kothari, Manas Dube, Chloe Constantinou, Teresa Fernandez Cuadrafo, Jane Macaskill, Hazem Khout, Anupama Nagarajakumar, Rob Milligan, Laura Arthur, Ricardo Pardo, Peter Barry, Emanuele Garreffa, Jill Dietz, Shawna Willey, Judy Boughey, Susan Boolbol, Anne Peled

Original Laboratory Investigation

Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers

Melody A. Cobleigh, Kayla Viets Layng, Elizabeth Mauer, Brett Mahon, Adam J. Hockenberry, Abde M. Abukhdeir

Original Laboratory Investigation

Subspecialized breast pathologists have suboptimal interobserver agreement in Ki-67 evaluation using 20% as the cutoff

Di Ai, Gulisa Turashvili, Sandra Gjorgova Gjeorgjievski, Qun Wang, Abdulwahab M. Ewaz, Yuan Gao, Thi Nguyen, Chao Zhang, Xiaoxian Li

Correction

Correction to: Clinical characteristics and prognosis of postpartum breast cancer

Pill Sun Paik, Jung Eun Choi, Seok Won Lee, Young Joo Lee, Young-Joon Kang, Hyouk Jin Lee, Soo Youn Bae

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.